TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Phase: PHASE2 | Sponsor: M.D. Anderson Cancer Center | Compound: Psilocybin

Status

recruiting

Institution

M.D. Anderson Cancer Center

Start date

2025-05-23

End date

2029-03-31

Registry ID

NCT06801041

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.